Using a Western diet-induced outbred Swiss mouse model and an FVB strain Her2-mutant spontaneous breast cancer model, it has been shown that oral administration of Lactobacillus reuteri inhibits mammary tumorigenesis by CD4+CD25+ lymphocyte stimulation [13]. Here, CD4 is linked to breast carcinoma.